ArticleFrontiers in oncology2023

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer.

Rui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.